Betulinic acid prevents high glucose-induced expression of extracellular matrix protein in cardiac fibroblasts by inhibiting the TGF-β1/Smad signaling pathway
Authors:
- 1 May 2017
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 16 (5) , 6320-6325
Abstract
The proliferation and differentiation of cardiac fibroblasts (CFs) is central to cardiac fibrosis. Betulinic acid (BA) is an active compound isolated from the bark of the birch tree Betula spp. (Betulaceae) and has been shown to attenuate hepatic fibrosis. However, the effect of BA on the high glucose‑induced fibrosis response in CFs remains to be elucidated, therefore, the present study investigated the effect of BA on high glucose‑induced CFs and examined the possible mechanism underlying the effect of BA on CF transdifferentiation. CFs were pre‑incubated with various concentrations of BA for 24 h and then stimulated with high glucose (25 mM) for various times. Cell proliferation was evaluated using an MTT assay. The mRNA expression levels of α‑smooth muscle actin (SMA) and transforming growth factor (TGF)‑β1 were determined using reverse transcription‑quantitative polymerase chain reaction analysis. The protein expression levels of α‑SMA, collagen I, collagen III, fibronectin, TGF‑β1, small mothers against decapentaplegic (Smad)2/3, phosphorylated (p)‑Smad2 and p‑Smad3 and were detected using western blot analysis. The data revealed that BA attenuated the CF proliferation and myofibroblast differentiation induced by high glucose. In addition, BA inhibited the expression of extracellular matrix (ECM) in the CFs induced by high glucose. It was also found that BA inhibited the high glucose‑induced phosphorylation of Smad2/3 in the CFs. Taken together, BA suppressed the high glucose‑induced increase in the proliferation of CFs and expression of ECM via inhibition of the TGF‑β1/Smad signaling pathway. Thus, BA may offer therapeutic potential towards the treatment of cardiac fibrosis.Keywords
This publication has 27 references indexed in Scilit:
- Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signalingTranslational Research, 2015
- High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophyCardiovascular Diabetology, 2014
- The pathogenesis of cardiac fibrosisCellular and Molecular Life Sciences, 2013
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart diseaseFibrogenesis & Tissue Repair, 2012
- The origin of fibroblasts and mechanism of cardiac fibrosisJournal of Cellular Physiology, 2010
- Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblastsCardiovascular Research, 2007
- High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2Molecular and Cellular Biochemistry, 2007
- Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapyOncogene, 2005
- Betulinic Acid and Its Derivatives: A Review on their Biological PropertiesCurrent Medicinal Chemistry, 2005
- Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped virusesFitoterapia, 2003